Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start
Plus: Japan Accelerates Research As Outbreak Worsens
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.
